Cat Allergy in Humans Market will grow at a CAGR of 6.3% from 2022 to 2031 - Digital Journal

Cat Allergy in Humans Market Outlook 2031

• The global cat allergy in humans market was valued at US$ 4.2 Bn in 2021
• The global market is projected to grow at a CAGR of 6.3% from 2022 to 2031
• The global cat allergy in humans market is anticipated to exceed US$ 7.8 Bn by 2031

Overview of Cat Allergy in Humans Market

When people are exposed to various pets, such as dogs and cats, they develop a variety of allergies. The most common types of allergies are runny nose, sneezing, nasal congestion, itchy eyes, as well as skin rash. Allergies to cat is a human allergic reaction to allergens produced by cats. Cat allergens of the most common types are Fel d1 (secreted by the cat's sebaceous glands) and Fel d4 (found in the cat's saliva). pet allergy affects nearly 25% of allergic patients due to Fel d1 and Fel d4 proteins. Cat allergens, particularly Fel d1, are abundant in the form of dander and are thought to be a major cause of allergic asthma around the world. The primary treatment for allergic patients is to avoid cats. Certain allergy Treatment and allergy shots, on the other hand, can help control the symptoms of cat allergies.

Request a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84817

Rise in Adoption of Cats as Pets to Drive Global Market

Pet humanization is becoming a globally accepted term in the pet industry, as an increasing number of pet owners want to provide their pets with human-like products or experiences. For instance, according to Pet data, in 2018, the adoption rate for dogs in China was 11.8% and 19.9% for cats. Increase in R&D for drugs and vaccines for treatment or prevention of pet allergy is expected to drive the demand across the globe.

According to data from Allergy, Asthma & Immunology Research, in 2018, allergies to dogs and cats affected 10% to 20% of the global population with allergic rhino conjunctivitis and allergic asthma. Rising prevalence of various types of pet allergies, increasing investment by manufacturers in the development of novel Cat allergy therapeutics, and growing importance of self-medication are primary factors driving the market.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84817

Allergy-causing Genetic Traits to Contribute to Prevalence Rate of Allergy

An article published by Allergy U.K. stated that children born into families with a history of allergies are more likely to develop allergies as compared to other children. Increase in tendency of families and children to develop allergies due to their genetic links is known as 'being atopic'. Researchers have estimated that half of the children from atopic families are likely to have allergies themselves. However, this rate in children from non-atopic families is 1 in 5 children who may go on to have an allergy.

Along with lifestyle changes, changing climate with increased pollution, CO2 levels, and particulate matter (PM) across the world are pushing the prevalence and intensity of allergies. In 2020, according to the World Allergy Organization (WAO), allergic rhinitis was one of the most prevalent allergies, affecting 400 million people globally.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=84817

Preference for Antihistamine Medication Due to Immediate Relief and Easy Availability

In terms of treatment, the antihistamines segment is projected to dominate the market and account for 50% share by 2031. Antihistamines are the first line of treatment in case of pet allergies. They are cost-effective, easily available, and provide immediate relief. Antihistamines treat allergy symptoms such as nasal congestion, runny nose, sneezing, or itching, nasal passage enlargement, hives, and other skin rashes, and itchy, runny eyes. Treating these symptoms can help the patient feel better during the day and sleep better at night. The antihistamine dosage is determined by the allergy symptoms.

Increase in Prevalence of Allergic Rhinitis to Lead Global Cat Allergy in Humans Market

Based on application, the allergy treatment segment accounted for a major share of 95% of the global market in 2021. Easy availability and low cost of anti-allergy drugs are expected to drive the segment during the forecast period. The growth of the segment is due to rise in prevalence of allergic rhinitis and the expansion of government-funded healthcare programmes to raise awareness about cat litter allergy in humans. Increasing pollution levels around the world as well as distinct genetic changes are driving the allergy treatment segment. Moreover, increase in adoption of immunotherapy to treat pet allergy conditions, owing to good efficacy of therapy is expected to propel the segment over the next few years.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84817

Analysis of Key Players in Global Cat Allergy in Humans Market

The cat allergy in humans market report concludes with the company profiles section, which includes information about key players in the global cat allergy in humans market. Leading players analyzed in the report include Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma, Cipla Limited, GlaxoSmithKline plc, Merck & Co., Inc, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Sanofi, and Stallergenes Greer.

Each of these players has been profiled in the cat allergy in humans market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84817

Key Developments in Global Cat Allergy in Humans Market

• In March 2022, Perrigo Company plc, a leading provider of high-quality, low-cost self-care products, received FDA approval for the over-the-counter use of Nasonex 24HR pet Allergy Relief (mometasone furoate monohydrate 50mcg). This approval is the company's first branded Rx-to-OTC switch, paving the path for Nasonex to enter the OTC market. According to Perrigo, Nasonex 24HR Allergy is expected to be available later this year.
• In October 2021, the U.S. Food and Drug Administration (USFDA) approved Dupixent, which is used to treat moderate-to-severe asthma for patients aged six to eleven years. Dupixent (dupilumab) helps reduce asthma and pet allergy symptoms in individuals with cat allergies. The approval is expected to enable the company to expand its product portfolio.
• In June 2021, Bayer AG received FDA approval in the U.S. to transition the in-licensed medicine Astepro Allergy from prescription to over-the-counter status. Astepro pet Allergy is the first and only steroid-free antihistamine nasal spray sold over-the-counter in the U.S. The approval is estimated to help the company to expand its product line as well as its consumer base.

More Trending Reports by Transparency Market Research:

Arthroscopic Visualization Instruments Market – https://www.transparencymarketresearch.com/arthroscopic-visualization-instrument.html

Non-invasive Prenatal Testing Market – https://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html

Safety Pen Needles Market – https://www.transparencymarketresearch.com/north-america-safety-pen-needles-market.html

Smart Drug Delivery Systems Market – https://www.transparencymarketresearch.com/smart-drug-delivery-systems-market.html

Refurbished Medical Imaging Equipment Market – https://www.transparencymarketresearch.com/refurbished-medical-imaging-equipment-market.html

Trichoscope Devices Market – https://www.transparencymarketresearch.com/trichoscope-devices-market.html

Intraosseous Devices Market – https://www.transparencymarketresearch.com/intraosseous-devices-market.html

Magnetic Resonance Imaging Market – https://www.transparencymarketresearch.com/magnetic-resonance-imaging-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]